A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers

NCT00384397 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1128

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Meningitis
Measles
Mumps
Rubella
Varicella

Interventions

BIOLOGICAL: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine
BIOLOGICAL: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate
BIOLOGICAL: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate

Sponsor

Sanofi Pasteur, a Sanofi Company